RecruitingNCT05299294

Observational Study of the Use of 8% Capsaicin Patch in Children 0 to 18 Years Old

Observational Study of the Use of 8% Capsaicin Patch in Children 0 to 18 Years


Sponsor

University Hospital, Brest

Enrollment

160 participants

Start Date

May 12, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Patients aged less than 18-y with validated 8% capsaicin patch treatment in routine healthcare will be offered to participate the study. If they accept it as well as their parents, they will be included in the study . Medical data will be recorded and at home, the child or his family will collect pain assessment data. Tolerance will be monitored at home by phone call from investigational team every 24 hours until normalization. (Less than 24 hours for 75%, 100% to 72 hours on unpublished personal series.) Children will be assessed via scales at inclusion and 1-month, 3-month and 6-month.


Eligibility

Max Age: 17 Years

Inclusion Criteria3

  • chronic localized neuropathic pain
  • capsaicin 8% patch treatment indication validated in a pediatric chronic pain center
  • agreement for participation by child and parents

Exclusion Criteria3

  • already treated with capsaicin 8% patch in the same body area
  • already treated in the same study in an other investigation center
  • non willing to participate or parents not willing participation to the study

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERData collection

Collecting data on children receiving capsaicine 8% patch for localized neuropathic pain


Locations(20)

CHU Angers

Angers, France, France

CHU Bordeaux

Bordeaux, France, France

CHR Bourg en Bresse

Bourg-en-Bresse, France, France

CHU de Brest

Brest, France, France

CHU Caen

Caen, France, France

CHU Grenoble

Grenoble, France, France

CHU Lille

Lille, France, France

CHU Limoges

Limoges, France, France

CHU Marseille

Marseille, France, France

CHU Montpellier

Montpellier, France, France

CHU Nancy

Nancy, France, France

CHU Nantes

Nantes, France, France

CHU Robert Debré

Paris, France, France

CHU Trousseau

Paris, France, France

CHU Rouen

Rouen, France, France

CHRU Strasbourg

Strasbourg, France, France

CHU Toulouse

Toulouse, France, France

Institut Gustave Roussy

Villejuif, France, France

CHU d'Amiens

Amiens, France

CHU Lyon

Lyon, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05299294


Related Trials